French drugmaker Sanofi recently filed suit against federal agencies seeking details from contracts between 340B covered entities and outside pharmacies. [...] Read More »
Articles by : Rich Daly, Editor in Chief
A surge of recent drug manufacturer contract pharmacy policy changes may be driven by recent legal developments, new state laws, [...] Read More »
Irish drugmaker Alkermes will implement, on July 22, 340B contract pharmacy restrictions. The Dublin-based manufacturer is the 36th drugmaker to [...] Read More »
A federal legislative overhaul of the 340B program could provide Medicare savings for the federal government, according to a review [...] Read More »
Five drugmakers have issued recent refund notices to 340B covered entities for drug overcharges. In letters posted on the website [...] Read More »
Minnesota became the 7th state to enact a law to protect distribution of 340B drugs through contract pharmacies when the [...] Read More »
Drugmaker Novartis recently filed the second lawsuit that seeks to block implementation and enforcement of a recently enacted Mississippi law [...] Read More »
Bristol Myers Squibb (BMS) announced updates to its conditions on pharmaceutical sales involving contract pharmacies, requiring registered sites to be [...] Read More »
Vertex Pharmaceuticals has become the 33rd drugmaker to place 340B contract pharmacy restrictions, but the new policy exempts all six [...] Read More »
Drugmaker UCB recently told 340B providers in Arkansas that it will exempt them from its contract pharmacy restrictions. In a [...] Read More »